Fishman Jay A Ltd
- SEC CIK
- 0001006407
- Latest filing
- Jul 29, 2026
ARQT holding history
Arcutis Biotherapeutics, Inc. in every 13F filed by Fishman Jay A Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARQT overviewAll 13F holders of ARQTFull Q2 2026 holdings
- Shares (Q2 2026)
- 595,005
- Value
- $15.6M
- % of portfolio
- 1.2%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 595,005 | $15.6M | 1.2% | +28,275+5.0% | Added | Holders |
| Q1 2026 | 566,730 | $13.4M | 1.2% | +2,080+0.4% | Added | Holders |
| Q4 2025 | 564,650 | $16.4M | 1.3% | −1,000−0.2% | Reduced | Holders |
| Q3 2025 | 565,650 | $10.7M | 0.9% | +9,500+1.7% | Added | Holders |
| Q2 2025 | 556,150 | $7.80M | 0.7% | +23,000+4.3% | Added | Holders |
| Q1 2025 | 533,150 | $8.34M | 0.9% | −3,250−0.6% | Reduced | Holders |
| Q4 2024 | 536,400 | $7.47M | 0.7% | +118,400+28.3% | Added | Holders |
| Q3 2024 | 418,000 | $3.89M | 0.4% | +71,400+20.6% | Added | Holders |
| Q2 2024 | 346,600 | $3.22M | 0.3% | +122,300+54.5% | Added | Holders |
| Q1 2024 | 224,300 | $2.22M | 0.2% | +171,300+323.2% | Added | Holders |
| Q4 2023 | 53,000 | $171.2K | <0.1% | −34,000−39.1% | Reduced | Holders |
| Q3 2023 | 87,000 | $462.0K | 0.1% | +10,000+13.0% | Added | Holders |
| Q2 2023 | 77,000 | $733.8K | 0.1% | +13,200+20.7% | Added | Holders |
| Q1 2023 | 63,800 | $701.8K | 0.1% | +20,000+45.7% | Added | Holders |
| Q4 2022 | 43,800 | $648.2K | 0.1% | −3,000−6.4% | Reduced | Holders |
| Q3 2022 | 46,800 | $894.3K | 0.1% | +25,800+122.9% | Added | Holders |
| Q2 2022 | 21,000 | $447.5K | 0.1% | +21,000 | New | Holders |